Lexaria Bioscience Corp. - COM NEW (LEXX)

CUSIP: 52886N406

Q4 2023 13F Holders as of 31 Dec 2023

Type / Class
Equity / COM NEW
Total 13F shares
1,195,589
Share change
-577,175
Total reported value
$1,494,550
Price per share
$1.25
Number of holders
19
Value change
-$493,306
Number of buys
9
Number of sells
7

Quarterly Holders Quick Answers

What is CUSIP 52886N406?
CUSIP 52886N406 identifies LEXX - Lexaria Bioscience Corp. - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Lexaria Bioscience Corp. - COM NEW (LEXX) as of Q4 2023

As of 31 Dec 2023, Lexaria Bioscience Corp. - COM NEW (LEXX) was held by 19 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,195,589 shares. The largest 10 holders included Invenomic Capital Management LP, COWEN AND COMPANY, LLC, Connective Capital Management, LLC, GEODE CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, CITADEL ADVISORS LLC, Tower Research Capital LLC (TRC), UBS Group AG, 1832 Asset Management L.P., and ADAR1 Capital Management, LLC. This page lists 19 institutional shareholders reporting positions in this security for the Q4 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.